Real-world prognostic value of RET fusions in advanced non-small cell lung cancer (aNSCLC)

被引：0
|
作者：
Gadgeel, S. M. [1 ]
Zhang, Q. [2 ]
Lin, H. [3 ]
Fajardo, O. [4 ]
Trinh, H. [5 ]
Arndorfer, S. [6 ]
Kong, S. [7 ]
Rahman, A. [8 ]
Li, S. [9 ]
Archer, V. R. [10 ]
Gainor, J. F. [11 ]
机构：
[1] Henry Ford Hlth Syst, Dept Internal Med, Henry Ford Canc Inst, Detroit, MI USA
[2] Genentech Inc, Product Dev Data Sci, San Francisco, CA USA
[3] Roche Holding Ltd, Roche Product Dev Shanghai, Shanghai, CA, Peoples R China
[4] F Hoffmann La Roche Ltd, Product Dev Data Sci, Basel, Switzerland
[5] Genentech Inc, Product Dev Real World Data Sci, San Francisco, CA USA
[6] Genesis Res, Real World Evidence, Hoboken, NJ USA
[7] Genentech Inc, Biostat, San Francisco, CA USA
[8] Roche Prod Ltd, Product Dev Clin Dev, Welwyn Garden City, Herts, England
[9] Genentech Inc, Product Dev Oncol, San Francisco, CA USA
[10] Roche Prod Ltd, PDC, Welwyn Garden City, Herts, England
[11] Massachusetts Gen Hosp, Ctr Thorac Cancers, Dept Med, Canc Ctr, Boston, MA USA
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.2421
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1388P
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Real-world Afatinib Outcomes in Advanced Non-small Cell Lung Cancer Harboring EGFR Mutations
    Chen, Chi-Han
    Chang, John Wen-Cheng
    Chang, Ching-Fu
    Huang, Chen-Yang
    Yang, Cheng-Ta
    Kuo, Chih-Hsi Scott
    Fang, Yueh-Fu
    Hsu, Ping-Chih
    Wu, Chiao-En
    ANTICANCER RESEARCH, 2022, 42 (04) : 2145 - 2157
  • [42] Real-World Experience of Consolidation Durvalumab for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
    Barbaro, A.
    Mienko, F.
    Deng, L.
    Ohri, N.
    Halmos, B.
    Perez-Soler, R.
    Gucalp, R.
    Bodner, W.
    Cheng, H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S906 - S907
  • [43] Prevalence of Thromboembolic Events in Patients With Non-Small Cell Lung Cancer and RET Fusions
    Aldea, Mihaela
    Marinello, Arianna
    Guyon, David
    Gazzah, Anas
    Barlesi, Fabrice
    Planchard, David
    Besse, Benjamin
    JAMA ONCOLOGY, 2023, 9 (11) : 1583 - 1584
  • [44] Metronomic oral vinorelbine in a real-world population of advanced non-small cell lung cancer patients
    Estevinho, Fernanda
    Gomes, Rita
    Hasmucrai, Direndra
    Barata, Fernando
    PULMONOLOGY, 2022, 28 (05): : 368 - 375
  • [45] Validation of a Real-World Mortality Endpoint for Advanced Non-Small Cell Lung Cancer Patients in China
    Tang, X.
    Zhao, E.
    Liu, C.
    Xing, W.
    Liu, X.
    Zheng, Y.
    Li, H.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S995 - S995
  • [46] Real-World Efficacy and Safety of Anlotinib with and without Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Xiong, Q.
    Qin, B.
    Xin, L.
    Yang, B.
    Hu, Y.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S676 - S676
  • [47] Immune checkpoint inhibitors in advanced non-small cell lung cancer: Real-world survival and safety
    Tang, Monica
    Lee, Chee
    Lewis, Craig
    Boyer, Michael
    Brown, Bernadette
    Schaffer, Andrea
    Pearson, Sallie-Anne
    Simes, Robert
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2022, 18 : 30 - 31
  • [48] Real-World Efficacy and Safety of Anlotinib With and Without Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Xiong, Qi
    Qin, Boyu
    Xin, Lingli
    Yang, Bo
    Song, Qi
    Wang, Yu
    Zhang, Sujie
    Hu, Yi
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [49] A real-world study in advanced non-small cell lung cancer with de novo brain metastasis
    Lei, Lei
    Wang, Wen-xian
    Wang, Dong
    Lin, Li
    Zhu, You-cai
    Wang, Hong
    Wang, Li-ping
    Zhuang, Wu
    Fang, Mei-yu
    Wan, Bing
    Feng, Hui-jing
    Xu, Chun-wei
    JOURNAL OF CANCER, 2021, 12 (05): : 1467 - 1473
  • [50] Real-world experience of treatment with afatinib in advanced non-small cell lung cancer (NSCLC) in Vietnam
    Dong, H.
    Tuan, K. Nguyen
    Bui, T. T. P.
    Dong, H.
    ANNALS OF ONCOLOGY, 2022, 33 : S1590 - S1590
12345